These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11601878)

  • 21. Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.
    Kössi J; Vähä-Kreula M; Peltonen J; Risteli J; Laato M
    Arch Dermatol Res; 2004 May; 295(12):521-6. PubMed ID: 15045512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of epidermal stem cells to hypertrophic scars pathogenesis.
    Zhang GY; Li X; Chen XL; Li ZJ; Yu Q; Jiang LF; Ding J; Gao WY
    Med Hypotheses; 2009 Sep; 73(3):332-3. PubMed ID: 19427134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative ultrastructure of hypertrophic scars and keloids.
    Kischer CW
    Scan Electron Microsc; 1984; (Pt 1):423-31. PubMed ID: 6740239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nerve regeneration of hypertrophic scars and keloids after deep burns].
    Song Y; Cen Y; Xen XW; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):797-9. PubMed ID: 16334556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of keloid and hypertrophic scar; correlation of the water proton relaxation times with the duration of the scar.
    Babu M; Bai RP; Suguna L; Ramachandran K; Ramakrishnan KM
    Physiol Chem Phys Med NMR; 1993; 25(2):113-20. PubMed ID: 8397424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hypertrophic scars and keloids with a radiofrequency device: a study of collagen effects.
    Meshkinpour A; Ghasri P; Pope K; Lyubovitsky JG; Risteli J; Krasieva TB; Kelly KM
    Lasers Surg Med; 2005 Dec; 37(5):343-9. PubMed ID: 16365887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, aetiology and management of abnormal scarring: a review of the literature.
    Pellard S
    J Wound Care; 2006 Jan; 15(1):44-8. PubMed ID: 16669306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The keloid phenomenon: progress toward a solution.
    Louw L
    Clin Anat; 2007 Jan; 20(1):3-14. PubMed ID: 16944532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation.
    Hsu YC; Hsiao M; Wang LF; Chien YW; Lee WR
    Nitric Oxide; 2006 Jun; 14(4):327-34. PubMed ID: 16517189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is photodynamic therapy a solution for keloid?
    Nie Z
    G Ital Dermatol Venereol; 2011 Dec; 146(6):463-72. PubMed ID: 22095178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to Special Issue on Hypertrophic Scars and Keloids.
    Rohrer TE; Gold M
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S1-S2. PubMed ID: 28009688
    [No Abstract]   [Full Text] [Related]  

  • 35. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
    Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
    Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aetiology and management of hypertrophic scars and keloids.
    O'Sullivan ST; O'Shaughnessy M; O'Connor TP
    Ann R Coll Surg Engl; 1996 May; 78(3 ( Pt 1)):168-75. PubMed ID: 8779496
    [No Abstract]   [Full Text] [Related]  

  • 37. Management and prevention of abnormal scars.
    Devlin-Rooney K; James W
    Nurs Stand; 2005 Mar 23-29; 19(28):45-54; quiz 55-6. PubMed ID: 15819267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: a case series.
    Barolet D; Boucher A
    Lasers Surg Med; 2010 Aug; 42(6):597-601. PubMed ID: 20662038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of apoptosis by in situ labeling and study on the expression of PCNA in hypertrophic scars and keloids].
    Zhao BC; Qian L
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):73-6. PubMed ID: 12212258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keloid and hypertrophic scar: neurogenic inflammation hypotheses.
    Akaishi S; Ogawa R; Hyakusoku H
    Med Hypotheses; 2008; 71(1):32-8. PubMed ID: 18406540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.